...
首页> 外文期刊>African Journal of Biotechnology >Antiproliferative activity of recombinant human interferon-2 expressed in stably transformed BmN cells
【24h】

Antiproliferative activity of recombinant human interferon-2 expressed in stably transformed BmN cells

机译:在稳定转化的BmN细胞中表达的重组人干扰素2的抗增殖活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study aimed at the generation of a stable transformed silkworm BmN cell line which can continuously express human interferon-λ2 (IFN-λ2) gene, and investigated the antiproliferative activity of this recombinant human IFN-λ2. Silkworm BmN cells were transfected with the recombinant vector pIZT/V5-His harboring the human IFN-λ2 gene. After the BmN cells were transfected with the pIZT/V5-His- hIFN-λ2 vector, the stably transformed BmN cells expressing hIFN-λ2 gene were selected using Zeocin. Following two months of screening, the transformed BmN cell line was obtained.?Stable?transformed BmN cell line?can be maintained at a lower Zeocin concentration. The representing?26 kDa?protein band of?IFN-λ2 was detected by SDS-PAGE and Western blotting.?The expression level of hIFN-λ2, determined by ELISA, was about 8.142 ng?in?4?′?105?cells.?The antiproliferative activity of hIFN-λ2 was determined by MTT assay.?The 50% inhibitory concentrations (IC50) of the recombinant hIFN-λ2?on A549 (lung cancer cells), HL60 (acute promyelocytic leukemia cells), BEL-7402 (liver?cancer cells)?and M231 cells (breast cancer cells) were approximately 3.21, 2.84, 6.29 and 9.32 ng/ml, respectively. In summary, Human?IFN-λ2 can be stably expressed in the transformed BmN cell line, and the expressed recombinant hIFN-λ2 demonstrated antiproliferative activity to tumor cells?in vitro.
机译:这项研究旨在生成稳定的转化蚕BmN细胞系,该细胞系可以连续表达人干扰素-λ2(IFN-λ2)基因,并研究了该重组人干扰素-λ2的抗增殖活性。用具有人IFN-λ2基因的重组载体pIZT / V5-His转染家蚕BmN细胞。用pIZT /V5-His-hIFN-λ2载体转染BmN细胞后,用Zeocin筛选稳定表达hIFN-λ2基因的BmN细胞。筛选两个月后,获得了转化的BmN细胞系。可以将稳定的“转化的BmN细胞系”维持在较低的Zeocin浓度下。通过SDS-PAGE和Western blotting检测出代表性的?IFN-λ2的?26 kDa?蛋白条带。用ELISA法测定?IFN?λ2在?4?'?105?细胞中的表达水平约为8.142 ng?。通过MTT法测定hIFN-λ2的抗增殖活性。重组hIFN-λ2对A549(肺癌细胞),HL60(急性早幼粒细胞白血病细胞),BEL-7402的50%抑制浓度(IC50)。 (肝癌细胞)和M231细胞(乳腺癌细胞)分别约为3.21、2.84、6.29和9.32 ng / ml。总之,人αIFN-λ2可以在转化的BmN细胞系中稳定表达,并且表达的重组hIFN-λ2在体外对肿瘤细胞具有抗增殖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号